393 related articles for article (PubMed ID: 17671263)
21. Response to open peer commentaries on "The pitfalls of deducing ethics from economics: why the Association of American Medical Colleges is wrong about pharmaceutical detailing".
Huddle TS
Am J Bioeth; 2010 Jan; 10(1):W1-3. PubMed ID: 20077322
[No Abstract] [Full Text] [Related]
22. Drug representatives: giving you lunch or stealing your soul?
Higgins SP
Dermatol Online J; 2007 Oct; 13(4):5. PubMed ID: 18319002
[TBL] [Abstract][Full Text] [Related]
23. Financial conflicts of interest in physicians' relationships with the pharmaceutical industry--self-regulation in the shadow of federal prosecution.
Studdert DM; Mello MM; Brennan TA
N Engl J Med; 2004 Oct; 351(18):1891-900. PubMed ID: 15509824
[No Abstract] [Full Text] [Related]
24. Giving and receiving of gifts between pharmaceutical and medical specialists in Australia.
Wilson A
Intern Med J; 2006 Dec; 36(12):795-6; author reply 796-7. PubMed ID: 17096745
[No Abstract] [Full Text] [Related]
25. On the need for probity when physicians interact with industry.
Scott IA
Intern Med J; 2006 Apr; 36(4):265-9. PubMed ID: 16640747
[TBL] [Abstract][Full Text] [Related]
26. Crackdown urged on doc gifts.
Robeznieks A
Mod Healthc; 2008 May; 38(18):20. PubMed ID: 18557478
[No Abstract] [Full Text] [Related]
27. The devil is in the details: the pharmaceutical industry's use of gifts to physicians as marketing strategy.
McFadden DW; Calvario E; Graves C
J Surg Res; 2007 Jun; 140(1):1-5. PubMed ID: 17481979
[TBL] [Abstract][Full Text] [Related]
28. Medicine and the pharmaceutical industry: a call to action.
Stiles MM; Barrett B
Am Fam Physician; 2007 May; 75(10):1447, 1451; discussion 1451. PubMed ID: 17555137
[No Abstract] [Full Text] [Related]
29. Physician-industry interactions: there is no such thing as a free lunch.
Tsai HJ
Taiwan J Obstet Gynecol; 2008 Jun; 47(2):252-5. PubMed ID: 18603524
[No Abstract] [Full Text] [Related]
30. The hidden costs of free lunches: fraud and abuse in physician-pharmaceutical arrangements.
Gosfield AG
J Med Pract Manage; 2005; 20(5):253-8. PubMed ID: 15921138
[TBL] [Abstract][Full Text] [Related]
31. Winds of change: growing demands for transparency in the relationship between doctors and the pharmaceutical industry.
Barnes RK
Med J Aust; 2010 Mar; 192(5):294-5. PubMed ID: 20306549
[No Abstract] [Full Text] [Related]
32. Are gifts from pharmaceutical companies ethically problematic? A survey of physicians.
Brett AS; Burr W; Moloo J
Arch Intern Med; 2003 Oct; 163(18):2213-8. PubMed ID: 14557219
[TBL] [Abstract][Full Text] [Related]
33. Reforming pharmaceutical industry-physician financial relationships: lessons from the United States, France, and Japan.
Rodwin MA
J Law Med Ethics; 2011; 39(4):662-70. PubMed ID: 22084852
[TBL] [Abstract][Full Text] [Related]
34. Industry relations with emergency medicine graduate medical education programs.
Kowalenko T; Char D; Marco C; Asher S; Raja A; Farrell S; Sokolove PE;
Acad Emerg Med; 2009 Oct; 16(10):1025-30. PubMed ID: 19799581
[TBL] [Abstract][Full Text] [Related]
35. Lunch with Lilly: who pays?
Strong C
Am J Bioeth; 2003; 3(3):62-3. PubMed ID: 14594499
[No Abstract] [Full Text] [Related]
36. How will transparency redefine the relationship between physicians, patients, and the medical industry?
Katz LJ
Surv Ophthalmol; 2014; 59(3):345. PubMed ID: 24360791
[No Abstract] [Full Text] [Related]
37. Winds of change: growing demands for transparency in the relationship between doctors and the pharmaceutical industry.
Gough IR; Dickinson I; Maddern G; Grigg M; Hillis DJ
Med J Aust; 2010 Mar; 192(5):293-4. PubMed ID: 20201768
[No Abstract] [Full Text] [Related]
38. Should a medical practice accept a gift with strings attached?
Agrawal M; Steinberg D
Med Ethics (Burlingt Mass); 2001; ():3, 7. PubMed ID: 15584189
[No Abstract] [Full Text] [Related]
39. Ethics for the pediatrician: physician interaction with the pharmaceutical industry.
Cicero MX; Curi MB; Mercurio M
Pediatr Rev; 2011 Jan; 32(1):e1-3. PubMed ID: 21196498
[No Abstract] [Full Text] [Related]
40. Nurses and the pharmaceutical industry: part 2.
Olsen DP
Am J Nurs; 2009 Feb; 109(2):86-7. PubMed ID: 19300016
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
